Results 171 to 180 of about 9,830,791 (289)
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Retraction notice to "An empirical evaluation of technology acceptance model for Artificial Intelligence in E-commerce" [Heliyon 9 (2023) e18349]. [PDF]
Wang C +8 more
europepmc +1 more source
The Research on Bridge Engineering Risk Management and Assessment Model Based on BP Neural Network
Xin Wang, Yilin Wang
openalex +1 more source
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source
Optimum energy management of distribution networks with integrated decentralized PV-BES systems using SPEA2-based optimization approach. [PDF]
Aksbi A +9 more
europepmc +1 more source
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Blockchain Technology for Big-data Sharing in Material Genome Engineering. [PDF]
Wang R +6 more
europepmc +1 more source
Introduction: Advances in e-business engineering and management [PDF]
Pan Wang, Sohail S. Chaudhry, Li Da Xu
openalex +1 more source
Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Objective Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical.
Shivani Garg +9 more
wiley +1 more source

